News

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Sullivan & Cromwell is acting for longtime client Merck in its $3.9bn acquisition of US biotech company SpringWorks Therapeutics, which is being repped by Goodwin Procter.
Portugal's Galp will be gradually restarting units at its Sines oil refinery over the coming days after the major Iberian ...
U.S. President Donald Trump called Amazon Executive Chairman Jeff Bezos on Tuesday morning to complain about a report the ...
Robinhood Markets, Inc. (NASDAQ:HOOD) anticipates earnings per share of $0.32 and revenue of approximately $917.2 million for ...
Merck KGaA plans to acquire SpringWorks Therapeutics (NASDAQ:SWTX) for approximately $3.9 billion, aiming to enhance its ...
I think we’ve come a long way in understanding the importance of this biology. We know it affects men and women, children and adults,” Paul Mischel told the audience during his plenary talk at the ...
SpringWorks sells two rare tumors drugs in the US and has two precision oncology drugs in early-stage development.
The health sector is navigating various challenges, including debates over drug pricing in the EU, pest agreements between ...
A German pharmaceutical company is acquiring a drug developer with operations in Research Triangle Park.
In a press release, Merck KGaA CEO and chair of the executive board Belen Garijo said, “The agreed acquisition of SpringWorks is a major step in our active portfolio strategy to position Merck KGaA, ...
Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks ...